Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

NCT00485823 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenic Disorders

Interventions

DRUG: Olanzapine Hydrochloride
PROCEDURE: Weight Management Program

Sponsor

Eli Lilly and Company